Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2

British Journal of Cancer

Volumn 66, Issue 6, 1992, Pages 1195-1199

  Miles, D W ^a   Aderka, D ^b   Engelmann, H ^c   Wallach, D ^c   Balkwill, F R ^d  

^a GUY S HOSPITAL   (United Kingdom)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; INTERLEUKIN 2; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RECEPTOR SOLUBILIZATION; SIDE EFFECT;

BREAST NEOPLASMS; CARCINOMA, RENAL CELL; DRUG ADMINISTRATION SCHEDULE; HUMAN; INTERLEUKIN-2; KIDNEY NEOPLASMS; MELANOMA; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR;

EID: 0027065027     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1992.435     Document Type: Article

References (25)

1. ADERKA, D., ENGELMANN, H., HORNIK, V., SKORNICK, Y., LEVO, Y., WALLACH, D. & KUSHTAI, G. (1991). Increased serum levels of soluble receptors for tumour necrosis factor in cancer patients. Cancer Res., 51, 5602-5607
2. ADERKA, D., ENGELMANN, H., MAOR, Y., BRAKEBUSCH, C. & WALLACH, D. (1992). Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J. Exp. Med., 175, 323-329
3. BLAY, J. Y., FAVROT, M. C., NEGRIER, S., COMBARET, G., CHOUAIB, S., MERCATELLO, A., KAEMMERLEN, P., FRANKS, C. R. & PHILIP, T. (1990). Correlation between clinical response to interleukin-2 therapy and sustained production of tumour necrosis factor. Cancer Res., 50, 2371-2374
4. CHOUAIB, S., BERTOGLIO, J., BLAY, J. Y., MARCHOL-FOURNI-GAULT, C. & FRADELEZI, D. (1988). Generation of lymphokine-activated killer cells: synergy between tumour necrosis factor and interleukin-2. Proc. Natl Acad. Sci. USA, 85, 6875-6879
5. ENGELMANN, H., NOVICK, D. & WALLACH, D. (1990). Two tumour necrosis-binding proteins purified from human urine. J. Biol. Chem., 265, 1531-1536
6. GEMLO, B. T., PALLADINO, M. A., JAFFE, H. S., ESPEVIK, T. P. & RAYNER, A. A. (1988). Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin-2 and lymphokine activated killer cells. Cancer Res., 48, 5864-5867
7. GERLACH, H., LIEBERMAN, H., BACH, R., GODMAN, G., BRETT, J. & STERN, D. (1989). Enhanced responsiveness of endothelium in the growing/motile state to tumour necrosis factor/cachectin. J. Exp. Med., 170, 913-931
8. HEBERMAN, R. B. (1989). Interleukin-2 therapy of human cancer: potential benefits versus toxicity. J. Clin. Oncol., 7, 1-4
9. HEILIG, B., MAPARA, M., BROCKHAUS, M., KRAUTH, K. & DORKEN, B. (1991). Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clinical Immunol. Immunopathol., 61, 260-267
10. LANTZ, M., MALIK, S., SLEVIN, M. & OLSSON, I. (1990). Infusion of tumour necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine, 2, 402-406
11. LOETSCHER, H., GENTZ, R., ZULAUF, M., LUSTIG, A., TABUCH, H., SCHLAEGER, E. J., BROCKHAUS, M., GALLATI, H., MANNEBERG, M. & LESSLAUER, W. (1991). Recombinant 55-kDa tumour necrosis factor (TNF) receptor. Stoichiometry of binding to TNFa and TNFb and inhibition of TNF activity. J. Biol. Chem., 266, 18324-18329
12. LOTZE, M. T., MATORY, Y. L., ETTINGHAUSEN, S. E., RAYNER, A. A., SHARRON, S O., SEIPP, C. A., CUSTER, M. C. & ROSENBERG, S. A. (1985). In vivo administration of purified interleukin-2 II. Half life, immunological effects and expansion of peripheral lymphoid cells in vivo with recombinant interleukin-2. J. Immunol., 135, 2865-2875
13. MILES, D. W., BIRD, C. R., WHADHWA, M., SUMMERHAYS, M., BALKWILL, F. R., THORPE, R. & RUBENS, R. D. (1990). Interleukin-2 for infusion should be reconstituted with albumin. Lancet, 336, 1602-1603
14. MUNKER, R., DI PERSIO, J. & KOEFFLER, H. P. (1987). Tumour necrosis factor: receptors on haematopoetic cells. Blood, 70, 1730-1734
15. OSTENSEN, M. E., THIELE, D. L. & LIPSKY, P. E. (1987). Tumour necrosis factor alpha enhances cytolytic activity of human natural killer cells. J. Immunol., 138, 4185-4191
16. OWEN-SCHAUB, L., CRUMP, W. L. & MORIN, G. I. (1989). E. A. G. regulation of lymphocyte tumour necrosis factor receptors by IL-2. J. Immunol., 143, 2236-2241
17. OWEN-SCHAUB, L. B., GUTTERMAN, J. U. & GRIMM, E. A. (1988). Synergy of tumour necrosis factor and interleukin-2 in the activation of human cytotoxic T-lymphocytes: effect of tumour necrosis factor alpha and interleukin-2 in the generation of human lymphocyte activated killer cell cytotoxicity. Cancer Res., 48, 788-792
18. PORTEU, F., BROCKHAUS, M., WALLACH, D., ENGELMANN, H. & NATHAN, C. F. (1991). Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumour necrosis factor (TNF) receptor. J. Biol. Chem., 266, 18846-18853
19. RADOUX, D. & de GROOTE, D. (1992). The total cytokine concept: the influence of soluble receptors in the cytokine measurement. Clinical correlations in pathology. Eur. Cytokine Network, 3, 204
20. RANGES, G. E., FIGARI, I S., ESPEVIK, T. & PALLADINO, M. A. (1987). Inhibition of cytotoxic T-cell development by transforming growth factor beta and reversal by recombinant tumour necrosis factor alpha. J. Exp. Med., 166, 991-998
21. RUGGIERO, V., TAVERNIER, J., FIERS, W. & BAGLIONI, C. (1986). Induction of tumour necrosis factor receptors by interferon-y. J. Immunol., 139, 2445-2450
22. SECKINGER, P., ISAAZ, S. & DAYER, J. (1988). A human inhibitor for tumour necrosis factor. J. Exp. Med., 167, 1511-1516
23. SCHEURICH, P., THOMA, B., ÜCER, U. & PFIZENMAIER, K. (1987). Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of TNF receptors on human T cells and TNF-a-mediated enhancement of T cell responses. J. Immunol., 6, 1786-1790
24. TRACEY, K. J., FONG, Y., HESSE, D. G., MANOGUE, K. R., LEE, A T., KUO, G. C., LOWRY, S. F. & CERAMI, A. (1987). Anti-cachetin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662-665
25. WARE, C. F., CROWE, P. D., VANARSDALE, T. L., ANDREWS, J. L., GRAYSON, M. H., JERZY, R., SMITH, C. A. & GOODWIN, R. G. (1991). Tumour necrosis factor (TNF) expression in T-lymphocytes. Differential regulation of the type 1 TNF receptor during activation of resting and effector T cells. J. Immunol., 147, 4229-4238